Browsing Tag
Rocket Pharmaceuticals
3 posts
Why Rocket Pharmaceuticals shareholders are filing suit over adverse event risks in RP-A501
A class action lawsuit claims Rocket Pharmaceuticals misled investors about the safety and effectiveness of its gene therapy. Find out what’s at stake.
Rocket Pharmaceuticals receives FDA clearance to begin human trials for RP-A701 in treating BAG3-associated dilated cardiomyopathy
Rocket Pharmaceuticals earns FDA IND clearance for RP-A701, advancing gene therapy for rare BAG3-associated dilated cardiomyopathy. Trial begins in U.S.
Rocket Pharmaceuticals gets FDA fast track status for RP-L401 in infantile malignant osteopetrosis
Rocket Pharmaceuticals has secured fast track designation for RP-L401 gene therapy candidate from the US Food and Drug…